SG Americas Securities
IDIX

SG Americas Securities’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

SG Americas Securities’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-529,579
Closed -$12.8M – 3013
2014
Q2 		$12.8M Buy
529,579
+488,441
+1,187% +$5.09M 0.07% 270
2014
Q1 		$248K Buy
+41,138
New +$287K ﹤0.01% 1846
2013
Q4 		– Sell
-19,132
Closed -$100K – 3369
2013
Q3 		$100K Buy
+19,132
New +$83.8K ﹤0.01% 2660

SG Americas Securities's IDIX Position: Q3 2014 in Review

SG Americas Securities sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 529,579 shares — an estimated $12.8M sold.

SG Americas Securities first reported a position in IDIX in Q3 2013 and held it in 3 quarters. The position peaked at $12.8M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • SG Americas Securities reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • SG Americas Securities sold 529,579 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $12.8M.
  • SG Americas Securities first reported a position in IDENIX PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
  • SG Americas Securities's IDENIX PHARMACEUTICALS INC position peaked at $12.8M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on SG Americas Securities's 13F filing for Q3 2014, filed 13 Nov 2014.